Why is Perseris Being Discontinued? A Look at the Financial and Market Factors
•
3 min read
Effective July 9, 2024, pharmaceutical company Indivior announced it would discontinue all sales and marketing activities for its schizophrenia drug, Perseris. This strategic move was not prompted by any safety or efficacy issues with the product but was a business decision based on financial viability, which answers the question: **Why is Perseris being discontinued**?. The market withdrawal was driven by increased payor management impacts and a competitive market landscape influenced by the Inflation Reduction Act.
